Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 04:28:21 14/06/2024 BST			5-day change	1st Jan Change
0.14 ^AUD	+5.66%		0.00%	-30.00%

05-30	Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call
05-08	Universal Biosensors Raises AU$10 Million via Entitlement Offer	MT

Universal Biosensors, Inc. Names John Sharman as Chief Executive Officer, Effective from 8 June 2020

May 25, 2020 at 12:01 am

On 6 March 2020, Universal Biosensors, Inc. announced the appointment of John Sharman as the Company's Chief Executive Officer. The company now announced that Mr. Sharman will commence in the role on 8 June 2020.

Latest news about Universal Biosensors, Inc.

Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	05-30
Universal Biosensors Raises AU$10 Million via Entitlement Offer	05-08	MT
Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%	05-02	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Universal Biosensors Opens AU$10 Million Rights Issue	04-19	MT
Universal Biosensors to Raise AU$10 Million for Technology Development	04-11	MT
H&G High Conviction Reports Flat Performance for March Quarter	04-10	MT
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	04-10
Australian Shares Rise as Central Bank Maintains Interest Rates	03-19	MT
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	03-19	MT
Transcript : Universal Biosensors, Inc., 2023 Earnings Call, Mar 07, 2024	03-07
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	03-01	MT
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Universal Biosensors Grows H2 2023 Sales by 55%	01-31	MT
Transcript : Universal Biosensors, Inc., Q3 2023 Earnings Call, Nov 02, 2023	11-01
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/10/23	CI
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	04/10/23	MT
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	31/08/23	MT
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	09/08/23	MT
Transcript : Universal Biosensors, Inc., Q2 2023 Earnings Call, Aug 08, 2023	08/08/23
Australian Shares Flat Ahead of Central Bank Policy Meeting	31/07/23	MT
Universal Biosensors Narrows Net Loss 74% in H1	31/07/23	MT
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	30/07/23	CI
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/07/23	CI
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	22/05/23

Chart Universal Biosensors, Inc.

Duration

Period

More charts

Company Profile

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.

Sector

Advanced Medical Equipment & Technology

Calendar

25/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UNIVERSAL BIOSENSORS, INC.	-30.00%	26.22M
DANAHER CORPORATION	+10.16%	189B
INTUITIVE SURGICAL, INC.	+26.21%	150B
BOSTON SCIENTIFIC CORPORATION	+32.78%	113B
SIEMENS HEALTHINEERS AG	+1.98%	65.05B
EDWARDS LIFESCIENCES CORPORATION	+14.48%	52.83B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.92%	49.39B
AGILENT TECHNOLOGIES, INC.	-6.60%	38.1B
GE HEALTHCARE TECHNOLOGIES INC.	-1.07%	35.14B
RESMED, INC.	+23.08%	31.2B

Other Advanced Medical Equipment & Technology